Stem Cell Clinic

Stem Cells Offer Hope to Those with Parkinson’s Disease – Legal Examiner

Parkinsons disease is a progressive degenerative illness that causes damage and nerve cell loss in the brain. The dopamine-producing cells are vital for smooth and controlled muscle movement. The loss of these cells due to Parkinsons disease is currently irreparable, and treatment is limited. While theres not yet a cure for the disease, there is reason for hope. Theres been significant advancement in clinical research studies using human stem cells to repair the damaging effects of Parkinsons disease.

Parkinsons disease worsens over time but is a very individual illness. Beginning with minor symptoms such as a hand tremor, the progression of the illness can lead to life-changing symptoms that include difficulty swallowing and speaking, impaired balance, and limb rigidity. Medications that pass chemicals to the brain to produce dopamine are available, but theyre a form of symptom management not a cure and cannot give back whats been lost. A treatment that repairs and replaces motor control cells using stem cells would improve the quality of life for many and open the door to treatments for other neurological illnesses and injuries. Progress is being made.

A recent study showed stem cells repaired Parkinsons degeneration in mice, an encouraging result that brings us one step closer to achieving the same effect in humans. The mice were implanted with nerve cells created using stem cells, and four to five months later, they displayed improved motor skills, bringing back movement that had been impaired. While human brains are much larger and complex, this studys results have reinforced the potential of stem cell treatments. To reverse whats currently permanent damage and replace cells that died from Parkinsons disease would give back so much to those suffering and be an enormous breakthrough for science.

Stem cells have already been used to treat a range of illnesses and injuries. They are a part of countless studies in the medical field because of their almost unbelievable capabilities. Given the right conditions, stem cells can replicate any cell in the human body and can even help grow tissues and organs. But the trick for researchers focusing on treatment for Parkinsons disease is to learn how the cells they are replicating act once put in the brain and whether the circuit they create leads to the correct result.

Muscle movement, everything from walking to talking, is a complex process. Our brains send signals to other parts of our brain, and the path they take and connections they make are an important piece of the puzzle. Research studies like that of the mice focus on tracking the circuits of these signals. If understood and able to control, they could enable doctors to place replicated cells to cultivate and recreate a healthy, functioning circuit that repairs whats lost by Parkinsons and other neurological diseases.

An area researchers have already seen success is repairing damaged corneas with stem cells. They took cells from their patients healthy eyes and used them to treat damage caused by an injury in the other eye. This, among other clinical trials, shows the significance and power of stem cell treatments. However, like many other journeys to scientific discovery, there have been negative effects and outright failures that call into question whether the risks are worth pursuing the reward.

The possibilities of stem cells seem endless, but as much success researchers have seen in this areas advancement, there are many victims of stem cell therapy malpractice. Patients have had procedures done with the promise of healing and improving their lives only to end up in worse condition than before the treatment. With as many as 1,000 stem cell treatment centers in the U.S. and no precedent for negligence and accountability, reining in the industry to protect individuals hasnt and wont be easy.

The possibilities, mixed with many successes, is what continues to drive the field. Stem cells could change the face of medicine through saving and prolonging lives and reversing damage from illnesses and injuries. Parkinsons disease is just one of many that takes so much from its victims. Stem cell treatments could change that.

Read the original post:
Stem Cells Offer Hope to Those with Parkinson's Disease - Legal Examiner

Canine Stem Cell Therapy Market: Know about Impact of Covid-19 by Top Companies like MediVet Biologic, VetStem Biopharma, Stem Cell Vet, Regeneus…

The latest report published by Zeal Insider provides an in-depth analysis on the Canine Stem Cell Therapy Market with actual market values for the years 2018 and 2019 along with forecast for a period from 2020 to 2028. Thereby, the report provides historic market figures for the years 2018 and 2019 and offers an insight into the impact of COVID-19 on the Canine Stem Cell Therapy market for the forecast period from 2020 to 2028. The purpose of this study is to provide a detailed overview on the Canine Stem Cell Therapy market in pre-COVID-19 conditions and further provide information of how the market has changed since the onset of the pandemic.

Key players profiled in the report includes: MediVet Biologic, VetStem Biopharma, Stem Cell Vet, Regeneus Ltd, Okyanos, Aratana Therapeutics

Request for a Sample Report of Canine Stem Cell Therapy Market: https://www.zealinsider.com/report/1356/canine-stem-cell-therapy-market#sample

The investigative report provides a detailed analysis of the Canine Stem Cell Therapy market covering several aspects such as market dynamics, growth drivers, restraining factors, opportunities, challenges and recent developments in the market. The study has been collated based on exhaustive secondary research after studying numerous industry publications, government reports, company news and press releases. Further, these findings are backed by detailed primary research after interviewing numerous key opinion leaders, market participants, end-users and various other stakeholders in the Canine Stem Cell Therapy market.

The research report provides a detailed analysis on the Canine Stem Cell Therapy market segmented on the basis of type, application, end-use and geography. Thereby, the report aims to provide granular information on the performance of various product types based on its applications and end-use across key market countries across the world. The idea behind the report is to provide its audience with actionable insights on which market segments are more profitable currently and others which offer growth opportunities during the forecast period from 2020 to 2028.

The report provides a detailed competitive landscape including company profiles for leading market participants in the Canine Stem Cell Therapy market. Some of the details included in the company profile are product/service offering, financial information, business strategies and recent developments, among others. Furthermore, the report provides an in-depth company mapping based on their market share, revenues, growth and geographic presence. Thereby, the report includes a detailed analysis of various companies operating across the globe. Leading companies covered in the report include MediVet Biologic, VetStem Biopharma, Stem Cell Vet, Regeneus Ltd, Okyanos, Aratana Therapeutics, among others.

Place Inquiry for Buying or Customization of Report: https://www.zealinsider.com/report/1356/canine-stem-cell-therapy-market#inquiry

Canine Stem Cell Therapy Market Segmentation:

The report offers in-depth analysis of the Canine Stem Cell Therapy market based on various segments such as type, application and end-use industry. The Canine Stem Cell Therapy market is segmented as follows:

Canine Stem Cell Therapy Market, by Type: Allogeneic Stem Cells, Autologous Stem Cells

Canine Stem Cell Therapy Market, by Application: Veterinary Hospitals, Veterinary Clinics, Veterinary Research Institutes

Companies included in the Canine Stem Cell Therapy Market report: MediVet Biologic, VetStem Biopharma, Stem Cell Vet, Regeneus Ltd, Okyanos, Aratana Therapeutics

Geographic Coverage

The report on the Canine Stem Cell Therapy market provides a detailed country-level cross-sectional analysis across various regions around the globe. The report contains detailed market size and forecast for the following countries and regions:

North America Canine Stem Cell Therapy Market Revenue and Forecast

Europe Canine Stem Cell Therapy Market Revenue and Forecast

Asia Pacific Canine Stem Cell Therapy Market Revenue and Forecast

Latin America Canine Stem Cell Therapy Market Revenue and Forecast

Middle East and Africa Canine Stem Cell Therapy Market Revenue and Forecast

Access Full Report, here: https://www.zealinsider.com/report/1356/canine-stem-cell-therapy-market

This report provides an investigative analysis of the Canine Stem Cell Therapy market encapsulated in detailed sections such as

View post:
Canine Stem Cell Therapy Market: Know about Impact of Covid-19 by Top Companies like MediVet Biologic, VetStem Biopharma, Stem Cell Vet, Regeneus...

California Proposition 14: Funding medical research that uses stem cells – KTLA

Voting yes on Prop 14 means supporting stem cell research through a $5.5 billion state bond. Its a loan that California, through its taxpayer-supported general fund, would have to pay back with interest over 30 years.

Prop 14 would extend funding that has almost run out for the states stem cell research institute, which was created with the approval of California voters in 2004 after President George W. Bush banned federally funding studies that use newly created stem cell lines.

The research supports the development of treatments and cures for cancer, Alzheimers, heart disease and other medical conditions. Prop 14 also comes with new rules on spending the funds, including more access to stem cell treatment for patients.

Voting no on Prop 14 means rejecting a new bond to continue state funding for stem cell research.

Supporters: Cedars-Sinai, City of Hope, the Michael J. Fox Foundation and other research and patient advocacy groups have helped raise more than $6.5 million to promote Prop 14. The coalition says stem cell research has led to significant progress that includes clinical trials, more than 2,900 medical discoveries and benefits for patients with chronic diseases such as cancer, diabetes, HIV/AIDS and ALS.

Critics: No organized effort has raised money to oppose Prop 14, but some newspaper editorial boards such as the L.A. Times argue that the measure isnt the best way to back stem-cell research. The idea was never for California to become the long-term replacement for federal funding, the L.A. Times editorial board said. It was to kick-start an industry that would then operate on its own.

Read the original:
California Proposition 14: Funding medical research that uses stem cells - KTLA

Stem Cell Therapy Market Comprehensive Study COVID19 Impact Analysis 2020-2025 – The Think Curiouser

The global Stem Cell Therapy Market research report is a well synchronized synopsis highlighting some of the most significant, real time research analysis that enable quick and efficient business discretion. The report is a quick reference point to make comply with reader understanding of the volatile market situations that collectively steer enormous growth opportunities in the global Stem Cell Therapy Market. The report offers a resourceful outline highlighting various facets that encourage remunerative business decisions in this market. The report draws references of growth-oriented business strategies, concomitant competition, business decisions as well as includes references of dynamic segmentation that collectively ensure steady growth in the global market.

The report categorically sheds ample light on multiply market components such as major trends, persistent challenges as well as barriers and threats that significantly restrict growth in the global Stem Cell Therapy Market. Additionally, to meet with manufacturer needs of opportunity hunting, the report specifically outlines crucial references about major opportunities that steer steady growth and sustainable revenue streams in the global Stem Cell Therapy Market.

Download Sample PDF Brochure with Covid-19 Updates @ https://www.adroitmarketresearch.com/contacts/request-sample/691?utm_source=re

This Stem Cell Therapy Market report also strives to provide an essential understanding of the market development from a past and present perspective for accurate forecasting forecasts. In addition, important details of key market players are also included in the report, replicating the growth-oriented business discretion.

COVID-19 Specific Analysis

This up-to-date research report compilation also entices readers to get equipped with ongoing market developments inclusive of unprecedented developments such as COVID-19 outbreak that has crippled businesses and industrial developments in a myriad ways. The report is structured to highlight effective cues for growth oriented business decisions, allowing manufacturers and stakeholders in the Stem Cell Therapy Market to come up with growth friendly strategies and tactics.

Browse full research report @ https://www.adroitmarketresearch.com/industry-reports/stem-cell-therapy-market?utm_source=re

Understanding regional growth prognosis: global Stem Cell Therapy Market

The next section of the report on the global Stem Cell Therapy Market contains vivid details on regional developments, including details on country-specific events collectively impacting optimistic growth. In addition, important details of key market players are also included in the report, replicating the growth-oriented business discretion. This report also strives to provide an essential understanding of the market development from a past and present perspective for accurate forecasting forecasts.

Stem Cell Therapy Market Segmentation

Type Analysis of Stem Cell Therapy Market:

Based on cell source, the market has been segmented into,

Adipose Tissue-Derived Mesenchymal SCs Bone Marrow-Derived Mesenchymal SCs Embryonic SCs Other Sources

Applications Analysis of Stem Cell Therapy Market:

Based on therapeutic application, the market has been segmented into,

Musculoskeletal Disorders Wounds & Injuries Cardiovascular Diseases Gastrointestinal Diseases Immune System Diseases Other Applications

Guide to 5 Guidance for Investing in Reports

1. A thorough end-to-end review and analysis of Stem Cell Therapy Market events and their meaning 2. Thorough compilation of a wide range of market segments 3. Complete demonstration of industry best practices, careful business decisions, and manufacturer activities driving revenue sustainability in the global Stem Cell Therapy Market 4. A complete assessment of the competitive spectrum, including relevant details for key and emerging players 5. Accurate review of key dynamics and dominant changes influencing the growth of global Stem Cell Therapy Market.

Make An Enquiry About This Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/691?utm_source=re

About Us :

Contact Us :

Ryan Johnson Account Manager Global 3131 McKinney Ave Ste 600, Dallas, TX75204, U.S.A. Phone No.: USA: +1 972-362 -8199/ +91 9665341414

Read more:
Stem Cell Therapy Market Comprehensive Study COVID19 Impact Analysis 2020-2025 - The Think Curiouser

Stem Cell Therapy Market 2020 Industry Size, Trends, Global Growth, Insights And Forecast Research Report 2025 – PRnews Leader

A newly added research report highlighting the multi-faceted global Stem Cell Therapy Market is in place to offer report audience comprising new market aspirants, established market participants, research business consultants and the like who scout for significant breakthroughs to make futuristic investment discretion in global Stem Cell Therapy Market. The global market report reveals pertinent data on segment performance, growth potential in the coming years as well as vendor and manufacturer activities, aligning appropriately with consumption and production developments. Further details on consumer behavior, purchase preferences as well as developments across geographical hotspots are closely monitored to ensure error-free business decisions. Details on COVID-19 impact and probable damage recovery plans have been discussed at length to guide significant business decisions. The report further entails versatile details on various growth compliant regions of the market, focusing specially on Europe, America and APAC.

Download Sample PDF Brochure with Covid-19 Updates @ https://www.adroitmarketresearch.com/contacts/request-sample/691?utm_source=re

Some of the key reader queries that have been adequately addressed in the report include, top vendors and their growth triggering business strategies, regional outlook and growth hotspot identification, followed by prominent growth retardants, challenges and threat probability which result in dwarfed growth outlook. Further, to instill new market participation amongst novel enthusiast, Stem Cell Therapy Market report clearly focuses teeming business opportunities that ensure smooth rise despite odds and growing competition.

Browse full research report @ https://www.adroitmarketresearch.com/industry-reports/stem-cell-therapy-market?utm_source=re

Research output has been meticulously presented on the basis of astute acute primary and secondary research practices to arrive at logical and highly relevant business considerations based on which new and established players across market platform can effectively brainstorm lucrative business decisions to harness a cementing lead besides ensuring steady and long term revenue generation despite major dynamics alterations as well as catastrophic alterations that tend to reflect tremendous impact on holistic growth trajectory of global Stem Cell Therapy Market. The report is committed to unravelling key market developments across past and current timelines to deduce substantial market inputs governing market developments, novel investments, technological milestones as well as competition intensity which collectively lend significant growth momentum.

In-depth research suggests that global Stem Cell Therapy Market is a significantly fast growing one and is anticipated to remain ahead on the global growth chart, with tangible signs of growth restoration struck by the global pandemic. Key researchers suggest that the aforementioned market has demonstrated optimistic growth spurt through the past years and is therefore likely to follow the same patterns during the forecast span, 2020-25.

Stem Cell Therapy Market Segmentation

Type Analysis of Stem Cell Therapy Market:

Based on cell source, the market has been segmented into,

Adipose Tissue-Derived Mesenchymal SCs Bone Marrow-Derived Mesenchymal SCs Embryonic SCs Other Sources

Applications Analysis of Stem Cell Therapy Market:

Based on therapeutic application, the market has been segmented into,

Musculoskeletal Disorders Wounds & Injuries Cardiovascular Diseases Gastrointestinal Diseases Immune System Diseases Other Applications

Based on further research analysis cited in the Stem Cell Therapy Market report, this in-depth research presentation kindles novel value addition initiativeson the part of leading market participants, besides guiding them to re-design new investment flowcharts to muster ample competitive edge.

Thorough Analytical Review: Global Stem Cell Therapy Market

1. Comprehensive research derivatives and analytical inputs of the global Stem Cell Therapy Market are presented in the report in a bid to encourage high capitalization by aspiring players as well as prominent investors seeking stability and sustenance 2. This well researched report on global Stem Cell Therapy Market collates key findings and market growth highlights suggestive of keyword market progress through 2020-25. 3. A detailed analytical response of the growth propellants and key catalysts have been included to define evolution in global Stem Cell Therapy Market. 4. For maximum investment returns for key market players, this well researched report documentation on Stem Cell Therapy Market identifies prominent market segments, isolating the high-growth segment in the process. 5. This report offering highlightingglobal Stem Cell Therapy Market includes versatile details on various growth hotspots prevalent across geographical belts at global and local levels.

Make An Enquiry About This Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/691?utm_source=re

About Us :

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan Johnson Account Manager Global 3131 McKinney Ave Ste 600, Dallas, TX75204, U.S.A. Phone No.: USA: +1 972-362 -8199/ +91 9665341414

Go here to see the original:
Stem Cell Therapy Market 2020 Industry Size, Trends, Global Growth, Insights And Forecast Research Report 2025 - PRnews Leader

New reports shines light on Cancer Stem Cell Therapy Market Growth strategies adopted by top key players worldwide and assessment to 2026 – PRnews…

Worldwide Cancer Stem Cell Therapy Market Report consultation on the essential drivers and difficulties for market development experienced by the exporters and the market in every respect, and provides an overview of the main patterns emerging in the market. It also provides information on the Cancer Stem Cell Therapy market size of various stocks and their growth aspects, along with the main leading countries, various stakeholders such as investors, research and media, advisor, president, director, CEOs, traders, suppliers and others. Cancer Stem Cell Therapy Market Report covers the industry structure and even the landscape, the issues along with business strategies and market effectiveness.

The survey includes primary product information such as Cancer Stem Cell Therapy range, segmentation, perspective. Likewise, it includes static supply, Cancer Stem Cell Therapy investment opportunities, and factors that limit the growth of an organization. In particular, it provides Cancer Stem Cell Therapy product demand, annual procedures and industry growth facet. The emerging Cancer Stem Cell Therapy market area, along with the current market area, is helping key suppliers, decision-makers and readers plan different Cancer Stem Cell Therapy business policies accordingly.

>>> Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Cancer Stem Cell Therapy Market @

Top Competitors Targeting Cancer Stem Cell Therapy Market: AVIVA BioSciences, AdnaGen, Advanced Cell Diagnostics, Silicon Biosystems

The scope of the Cancer Stem Cell Therapy Market Research extends from the market scenarios for comparative pricing between the major players, services, costs and profits of the specified market regions. Cancer Stem Cell Therapy Market report examines the factors influencing market growth and product development along with technological up gradations that can boost the Cancer Stem Cell Therapy Market. The Cancer Stem Cell Therapy Industry report cites the various opportunities to favor market growth over the 2018-2026 forecast period. It also highlights the significant market trends shaping the market.

The top geographical regions studied in this research report include North America, Europe, Asia-Pacific, Middle East, and Africa, South America and the rest of the world. The growing Cancer Stem Cell Therapy Market and its progressive impact on the global economy is featured in this study. The competitive analysis of major Cancer Stem Cell Therapy Industry players, market size analysis, dynamics, as well as the qualitative and numerical assessment, is conducted. The insights offered in this study will determine the potential of Cancer Stem Cell Therapy Industry on global, regional and country-level paving the way for futuristic growth and investment feasibility.

Market Segmentation: By Type Autologous Stem Cell Transplants, Allogeneic Stem Cell Transplants, Syngeneic Stem Cell Transplants, Others

Market Segmentation: By Application Hospital, Clinic, Medical Research Institution, Others

The main parts in view of which the calculation of the Cancer Stem Cell Therapy market has been evaluated in this report are volume and income (US $). A full study of the Cancer Stem Cell Therapy markets key areas and the topographic separation from around the world are added. A few parts of the Cancer Stem Cell Therapy market, for example, the limitations, and future of each segment have been discussed in full. Furthermore, the Cancer Stem Cell Therapy market report rounds out the future projection of the Cancer Stem Cell Therapy market around the world.

The Cancer Stem Cell Therapy report has assimilated an analysis of late developments in innovation, key Cancer Stem Cell Therapy industry players, nitty gritty profiles and special model research. It provides worldwide Cancer Stem Cell Therapy showcase estimates for years to come.

>>> To get Incredible Discounts on this Premium Report, Click Here @ https://www.reporthive.com/2360734/check_discount

Table of Contents

Report Overview: It includes major players of the global Cancer Stem Cell Therapy Market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends: This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Cancer Stem Cell Therapy Market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Cancer Stem Cell Therapy Market are discussed.

Market Share by Manufacturers: Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type: This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application: Besides an overview of the global Cancer Stem Cell Therapy Market by application, it gives a study on the consumption in the global Cancer Stem Cell Therapy Market by application.

Production by Region: Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region: This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles: Almost all leading players of the global Cancer Stem Cell Therapy Market are profiled in this section. The analysts have provided information about their recent developments in the global Cancer Stem Cell Therapy Market, products, revenue, production, business, and company.

Market Forecast by Production: The production and production value forecasts included in this section are for the global Cancer Stem Cell Therapy Market as well as for key regional markets.

Market Forecast by Consumption: The consumption and consumption value forecasts included in this section are for the global Cancer Stem Cell Therapy Market as well as for key regional markets.

Value Chain and Sales Analysis: It deeply analyzes customers, distributors, sales channels, and value chain of the global Cancer Stem Cell Therapy Market.

Key Findings: This section gives a quick look at important findings of the research study.

>>> Make an enquiry before buying this report @ https://www.reporthive.com/2360734/enquiry_before_purchase

Why Report Hive Research:

Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc.

Contact Us:

Report Hive Research 500, North Michigan Avenue, Suite 6014, Chicago, IL 60611, United States Website: https://www.reporthive.com Email: [emailprotected] Phone: +1 312-604-7084

Excerpt from:
New reports shines light on Cancer Stem Cell Therapy Market Growth strategies adopted by top key players worldwide and assessment to 2026 - PRnews...

CSL’s Broad Response to COVID-19 and Advancements across the Company’s Strategic Scientific Platforms are the Focus of Annual R&D Day – PRNewswire

MELBOURNE, Australia and KING OF PRUSSIA, Pa., Oct. 20, 2020 /PRNewswire/ -- In its annual R&D briefing to investors today, CSL Limited (ASX:CSL; USOTC:CSLLY) demonstrated how the company is advancing a novel research portfolio across four strategic scientific platforms (Plasma Fractionation, Recombinant Technology, Cell and Gene Therapy, Adjuvanted Cell and Egg-based Vaccines) across six therapeutic areas (Immunology, Hematology, Respiratory, Cardiovascular and Metabolic, Transplant, Influenza Vaccines) and two businesses (CSL Behring and Seqirus) to help patients lead full lives, protect public health and drive future business growth. It's this scientific capability and diverse portfolio that positioned the company to quickly respond to the COVID-19 public health crisis.

"CSL's acumen in vaccines, monoclonal antibodies, recombinant technologies, manufacturing capabilities and external partnerships, along with a therapeutic area focus and insight that includes Immunology and Respiratory, has supported the growth and progress of our pipeline and has also enabled us to respond quickly to the need for potential solutions in the world's fight against COVID-19," said Bill Mezzanotte, MD, MPH,Executive Vice President, Head of Research and Development and Chief Medical Officer. "Right across the spectrum of infection and disease, CSL has taken on projects we think make sense both scientifically and that fit our capabilities."

The company's efforts in the fight against COVID-19 include:

"The same collaborative mindset with which CSL has responded to the COVID-19 pandemic is also reflected in how we are advancing our pipeline," said Andrew Nash, PhD, Senior Vice President, Head of Research and Chief Scientific Officer. "Across therapeutic areas, strategic platforms and geographies we continue to grow our footprint and capabilities so that we can deliver a significant benefit to patients around the world."

Other advancements in CSL's R&D pipeline in the last year include:

Setting the pace in Plasma Product development:CSL is continuously improving current plasma fractionation processes and developing new therapeutic options, which has shown major relevance in the fight against COVID-19 and is also evident in other therapeutic areas. For example:

Advancing its Cell and Gene Therapy research by:

Building momentum in Recombinant Technology:CSL has established a highly differentiated preclinical and clinical stage pipeline of recombinant proteins and monoclonal antibodies from its proficiency in protein biology and innate cell immunity. In addition to using this technology against COVID-19, the company is studying:

About CSL CSL (ASX:CSL) is a leading global biotechnology company with a dynamic portfolio of life-saving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL including our two businesses, CSL Behring and Seqirus - provides life-saving products to more than 70 countries and employs 27,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. For more information about CSL Limited, visitwww.csl.com.

SOURCE CSL

http://www.csl.com

Read more here:
CSL's Broad Response to COVID-19 and Advancements across the Company's Strategic Scientific Platforms are the Focus of Annual R&D Day - PRNewswire